Metabolic and psychiatric effects of acyl coenzyme A binding protein (ACBP)/diazepam binding inhibitor (DBI)
2020 · Cell Death and Disease · 41 citations
https://doi.org/10.1038/s41419-020-2716-5
G
Gerasimos Anagnostopoulos
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
57
Papers
1.4K
Citations
15
h-index
23
i10-index
Gerasimos Anagnostopoulos is an academic researcher from Université Paris-Saclay. The author has contributed to research in topics: Autophagy in Disease and Therapy & Liver Disease Diagnosis and Treatment & Cannabis and Cannabinoid Research. The author has an h-index of 15, co-authored 49 publications.
ORCID: 0000-0002-2042-8675Papers by this author
worksEffects of acyl-coenzyme A binding protein (ACBP)/diazepam-binding inhibitor (DBI) on body mass index
2021 · Cell Death and Disease · 36 citations
https://doi.org/10.1038/s41419-021-03864-9
ACBP/DBI neutralization for the experimental treatment of fatty liver disease
2024 · Cell Death and Differentiation · 12 citations
https://doi.org/10.1038/s41418-024-01410-6
Inhibition of acyl-CoA binding protein (ACBP) by means of a GABAARγ2-derived peptide
2024 · Cell Death and Disease · 11 citations
https://doi.org/10.1038/s41419-024-06633-6
Neutralization of acyl coenzyme A binding protein for the experimental prevention and treatment of hepatocellular carcinoma
2025 · Cell Reports Medicine · 5 citations
https://doi.org/10.1016/j.xcrm.2025.102232
The role of Acyl-CoA Binding protein/ Diazepam-Binding Inhibitor in obesity
2022 · theses.fr (ABES) · 0 citations
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat